Top Industry Leaders in the Global Blood Coagulants Market
Latest Blood Coagulants Companies Updates:
Bayer's novel BAY-1180923, an oral Factor XIa inhibitor, impressed in Phase 3 trials for preventing blood clots after hip or knee surgery. Its potential for reduced bleeding risk could shake up the anticoagulant landscape.
Janssen, meanwhile, secured FDA approval for Xarelto's use in preventing recurring blood clots in patients with a specific autoimmune condition. This personalized approach reflects the trend towards tailored treatments.
Hemonetics' next-gen HemoShear Elite Plus system leverages AI to optimize blood draw protocols and minimize complications. This intelligent approach enhances patient safety and reduces waste in blood collection.Verily Life Sciences, from the Alphabet family, is developing an AI model to predict bleeding risk in anticoagulant users. This personalized tool could revolutionize treatment plans and improve overall coagulation management.
List of Blood Coagulants Key companies in the market:
- Aptevo Biotherapeutics LLC
- Baxalta US Inc.
- Baxter Laboratories
- Bayer AG
- CSL Behring
- GRIFOLS USA, LLC
- Novo Nordisk A/S
- Octapharma
- Pfizer
- Shire
- SOBI